Inozyme Pharma Inc. (INZY) PT Raised to $43 at Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst Tyler Van Buren raised the price target on Inozyme Pharma Inc. (NASDAQ: INZY) to $43.00 (from $40.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
